| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 191.67M | — |
| Operating expense | — | — |
| Net income | 75.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ROVI.MC returned +5.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -4.1% |
| 1 year | +5.4% |
| 5 years | +24.1% |
| 10 years | +402.5% |
| All-time high | €89.00 (Jul 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ROVI.MC would be worth today ›Yes. Laboratorios Farmaceuticos Rovi, S.A. paid 1 dividend over the past 12 months. The most recent was €0.96 per share on Jul 13, 2026. The dividend yield is 1.60%.
Laboratorios Farmaceuticos Rovi, S.A. is part of the Healthcare sector.
Laboratorios Farmaceuticos Rovi, S.A. has a market cap of 3.06B EUR, based on the latest quote.
